(Q38241943)

31 August 2017

1 reference

title

Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back (English)

1 reference

31 August 2017

1 reference

Patrono C

1

1 reference

31 August 2017

language of work or name

1 reference

1 November 1989

1 reference

Trends in Pharmacological Sciences

31 August 2017

published in

1 reference

31 August 2017

volume

10

1 reference

31 August 2017

issue

11

1 reference

31 August 2017

page(s)

453-458

1 reference

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Effects of salicylates on human platelets.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

The eicosanoids and their biochemical mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Arachidonate metabolism in vascular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

The human pharmacology of platelet inhibition: pharmacokinetics relevant to drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Estimated rate of thromboxane secretion into the circulation of normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Inhibition of platelet prostaglandin synthetase by oral aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Clinical pharmacology of platelet cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Effect of Low-Dose Aspirin on Fetal and Maternal Generation of Thromboxane by Platelets in Women at Risk for Ppregnancy-Induced Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Clinical implications of prostaglandin and thromboxane A2 formation (1).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

The clinical significance of inhibition of renal prostaglandin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2889%2980010-0

7 January 2021

10.1016/S0165-6147(89)80010-0

Identifiers

DOI

1 reference

31 August 2017

1 reference